This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
Take Your Nursing Practice to the Next Level
View analytic
Thursday, April 23 • 10:00am - 11:00am
Treatment Considerations for Chronic Myeloid Leukemia (CML) Adult Patients After Multiple Tyrosine Kinase Inhibitor (TKI) Failures FULL

Sign up or log in to save this to your schedule and see who's attending!

Limited Capacity full
Adding this to your schedule will put you on the waitlist.

With the approval and launch of five oral tyrosine kinase inhibitors (TKIs) and one SQ protein synthesis inhibitor—as well as learnings and improvements in monitoring the disease—chronic myeloid leukemia (CML) has steadily transformed to an ever more “chronic” disease. Please join us for an overview of CML that will include the basics of the disease, with a focus on the management of patients in whom at least two TKIs have failed. We will review and discuss a relevant CML patient case and associated course of treatment.

This program is sponsored by Teva Oncology. 

Thursday April 23, 2015 10:00am - 11:00am
Learning Hall Theater 1 9800 International Drive, Orlando, FL 32819